Global Transdermal Drug Delivery System Sales Market Report 2020 by Manufacturer, Region, Type and Application

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

According to XYZResearch,in the last several years, global market of Transdermal Drug Delivery System developed rapidly, with an average sales growth rate of 13.4%. In 2016, global revenue of Transdermal Drug Delivery System was nearly 8000 million USD; the actual production is about 13300 million units.

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. The unprecedented global shift in the adoption of unhealthy lifestyles is to be responsible for the high prevalence of chronic diseases, such as cancer and diabetes, which is expected to drive the clinical urgency to incorporate transdermal drug delivery systems in the future treatments. Moreover, the rising geriatric population base, which is highly susceptible to developing the aforementioned chronic diseases are expected to propel the demand for highly efficacious pharmacological drugs.

The classification of Transdermal Drug Delivery System includes Fentanyl, Nitroglycerin, Estradiol, Nicotine and Other, and the revenue proportion of Fentanyl in 2016 was about 31%.

Transdermal Drug Delivery System can be used for OTC and Rx. The most proportion of Transdermal Drug Delivery System is OTC, and the sales proportion was about 83% in 2016.

Market competition is intense. Hisamitsu, Mylan, Johnson & Johnson, Actavis, etc. are the leaders of the industry.

North America was the largest sales place, with revenue market share nearly 41% in 2016. Following North America, Europe is the second largest sales place. China and Japan are also important sales regions for Transdermal Drug Delivery System.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Transdermal Drug Delivery System for these regions, from 2012 to 2023 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

Global Transdermal Drug Delivery System market competition by top manufacturers/players, with Transdermal Drug Delivery System sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
UCB
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
Other
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Transdermal Drug Delivery System for each application, including
OTC
Rx

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

1 Executive Summary
    1.1 Definition and Specification
    1.2 Report Overview
        1.2.1 Manufacturers Overview
        1.2.2 Regions Overview
        1.2.3 Type Overview
        1.2.4 Application Overview
    1.3 Industrial Chain
        1.3.1 Transdermal Drug Delivery System Overall Industrial Chain
        1.3.2 Upstream
        1.3.3 Downstream
    1.4 Industry Situation
        1.4.1 Industrial Policy
        1.4.2 Product Preference
        1.4.3 Economic/Political Environment
    1.5 SWOT Analysis
2 Market Analysis by Types
    2.1 Overall Market Performance(Volume)
         2.1.1 Fentanyl
         2.1.2 Nitroglycerin
         2.1.3 Estradiol
         2.1.4 Nicotine
         2.1.5 Other
    2.2 Overall Market Performance(Value)
         2.2.1 Fentanyl
         2.2.2 Nitroglycerin
         2.2.3 Estradiol
         2.2.4 Nicotine
         2.2.5 Other
3 Product Application Market
    3.1 Overall Market Performance (Volume)
         3.1.1 OTC
         3.1.2 Rx
4 Manufacturers Profiles/Analysis
    4.1 Hisamitsu
        4.1.1 Hisamitsu Profiles
        4.1.2 Hisamitsu Product Information
        4.1.3 Hisamitsu Transdermal Drug Delivery System Sales, Sales Value(Million USD), Price and Gross Profit
        4.1.4 Hisamitsu SWOT Analysis
    4.2 Mylan
        4.2.1 Mylan Profiles
        4.2.2 Mylan Product Information
        4.2.3 Mylan Transdermal Drug Delivery SystemSales, Sales Value (Million USD), Price and Gross Profit
        4.2.4 Mylan SWOT Analysis
    4.3 GSK
        4.3.1 GSK Profiles
        4.3.2 GSK Product Information
        4.3.3 GSK Transdermal Drug Delivery SystemSales, Sales Value (Million USD), Price and Gross Profit
        4.3.4 GSK SWOT Analysis
    4.4 Novartis
        4.4.1 Novartis Profiles
        4.4.2 Novartis Product Information
        4.4.3 Novartis Transdermal Drug Delivery SystemSales, Sales Value (Million USD), Price and Gross Profit
        4.4.4 Novartis SWOT Analysis
    4.5 Teve (Actavis)
        4.5.1 Teve (Actavis) Profiles
        4.5.2 Teve (Actavis) Product Information
        4.5.3 Teve (Actavis) Transdermal Drug Delivery SystemSales, Sales Value (Million USD), Price and Gross Profit
        4.5.4 Teve (Actavis) SWOT Analysis
    4.6 Johnson & Johnson
        4.6.1 Johnson & Johnson Profiles
        4.6.2 Johnson & Johnson Product Information
        4.6.3 Johnson & Johnson Transdermal Drug Delivery SystemSales, Sales Value (Million USD), Price and Gross Profit
        4.6.4 Johnson & Johnson SWOT Analysis
    4.7 UCB
        4.7.1 UCB Profiles
        4.7.2 UCB Product Information
        4.7.3 UCB Transdermal Drug Delivery SystemSales, Sales Value (Million USD), Price and Gross Profit
        4.7.4 UCB SWOT Analysis
    4.8 Teikoku Seiyaku
        4.8.1 Teikoku Seiyaku Profiles
        4.8.2 Teikoku Seiyaku Product Information
        4.8.3 Teikoku Seiyaku Transdermal Drug Delivery SystemSales, Sales Value (Million USD), Price and Gross Profit
        4.8.4 Teikoku Seiyaku SWOT Analysis
    4.9 Bayer
        4.9.1 Bayer Profiles
        4.9.2 Bayer Product Information
        4.9.3 Bayer Transdermal Drug Delivery SystemSales, Sales Value (Million USD), Price and Gross Profit
        4.9.4 Bayer SWOT Analysis
    4.10 Lingrui
        4.10.1 Lingrui Profiles
        4.10.2 Lingrui Product Information
        4.10.3 Lingrui Transdermal Drug Delivery SystemSales, Sales Value (Million USD), Price and Gross Profit
        4.10.4 Lingrui SWOT Analysis
    4.11 Sanofi
    4.12 Qizheng
    4.13 Endo
    4.14 Huarun 999
    4.15 Haw Par
    4.16 Nichiban
    4.17 Mentholatum Company
    4.18 Laboratoires Genevrier
    4.19 Other
5 Market Performance for Manufacturers
    5.1 Global Transdermal Drug Delivery System Sales (K Units) and Market Share by Manufacturers 2014-2020
    5.2 Global Transdermal Drug Delivery System Revenue (M USD) and Market Share by Manufacturers 2014-2020
    5.3 Global Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers 2014-2020
    5.4 Global Transdermal Drug Delivery System Gross Margin of Manufacturers 2014-2020
    5.5 Market Concentration
6 Regions Market Performance for Manufacturers
    6.1 China Market Performance for Manufacturers
        6.1.1 China Transdermal Drug Delivery System Sales (K Units) and Share of Manufacturers 2014-2020
        6.1.2 China Transdermal Drug Delivery System Revenue (M USD) and Share of Manufacturers 2014-2020
        6.1.3 China Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers 2014-2020
        6.1.4 China Transdermal Drug Delivery System Gross Margin of Manufacturers 2014-2020
        6.1.5 Market Concentration
    6.2 USA Market Performance for Manufacturers
        6.2.1 USA Transdermal Drug Delivery System Sales (K Units) and Share of Manufacturers 2014-2020
        6.2.2 USA Transdermal Drug Delivery System Revenue (M USD) and Share of Manufacturers 2014-2020
        6.2.3 USA Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers 2014-2020
        6.2.4 USA Transdermal Drug Delivery System Gross Margin of Manufacturers 2014-2020
        6.2.5 Market Concentration
    6.3 Europe Market Performance for Manufacturers
        6.3.1 Europe Transdermal Drug Delivery System Sales (K Units) and Share of Manufacturers 2014-2020
        6.3.2 Europe Transdermal Drug Delivery System Revenue (M USD) and Share of Manufacturers 2014-2020
        6.3.3 Europe Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers 2014-2020
        6.3.4 Europe Transdermal Drug Delivery System Gross Margin of Manufacturers 2014-2020
        6.3.5 Market Concentration
    6.4 Japan Market Performance for Manufacturers
        6.4.1 Japan Transdermal Drug Delivery System Sales (K Units) and Share of Manufacturers 2014-2020
        6.4.2 Japan Transdermal Drug Delivery System Revenue (M USD) and Share of Manufacturers 2014-2020
        6.4.3 Japan Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers 2014-2020
        6.4.4 Japan Transdermal Drug Delivery System Gross Margin of Manufacturers 2014-2020
        6.4.5 Market Concentration
    6.5 Korea Market Performance for Manufacturers
        6.5.1 Korea Transdermal Drug Delivery System Sales (K Units) and Share of Manufacturers 2014-2020
        6.5.2 Korea Transdermal Drug Delivery System Revenue (M USD) and Share of Manufacturers 2014-2020
        6.5.3 Korea Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers 2014-2020
        6.5.4 Korea Transdermal Drug Delivery System Gross Margin of Manufacturers 2014-2020
        6.5.5 Market Concentration
    6.6 India Market Performance for Manufacturers
        6.6.1 India Transdermal Drug Delivery System Sales (K Units) and Share of Manufacturers 2014-2020
        6.6.2 India Transdermal Drug Delivery System Revenue (M USD) and Share of Manufacturers 2014-2020
        6.6.3 India Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers 2014-2020
        6.6.4 India Transdermal Drug Delivery System Gross Margin of Manufacturers 2014-2020
        6.6.5 Market Concentration
    6.7 Southeast Asia Market Performance for Manufacturers
        6.7.1 Southeast Asia Transdermal Drug Delivery System Sales (K Units) and Share of Manufacturers 2014-2020
        6.7.2 Southeast Asia Transdermal Drug Delivery System Revenue (M USD) and Share of Manufacturers 2014-2020
        6.7.3 Southeast Asia Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers 2014-2020
        6.7.4 Southeast Asia Transdermal Drug Delivery System Gross Margin of Manufacturers 2014-2020
        6.7.5 Market Concentration
    6.8 South America Market Performance for Manufacturers
        6.8.1 South America Transdermal Drug Delivery System Sales (K Units) and Share of Manufacturers 2014-2020
        6.8.2 South America Transdermal Drug Delivery System Revenue (M USD) and Share of Manufacturers 2014-2020
        6.8.3 South America Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers 2014-2020
        6.8.4 South America Transdermal Drug Delivery System Gross Margin of Manufacturers 2014-2020
        6.8.5 Market Concentration
7 Global  Transdermal Drug Delivery System Market Assessment by Regions (2014-2020)
    7.1 Global Transdermal Drug Delivery System Sales (K Units) and Market Share by Regions 2014-2020
    7.2 Global Transdermal Drug Delivery System Revenue (M USD) and Market Share by Regions 2014-2020
    7.3 Global Transdermal Drug Delivery System Price (USD/Unit) by Regions 2014-2020
    7.4 Global Transdermal Drug Delivery System Gross Margin by Regions 2014-2020
8 Development Trend for Regions
    8.1 Global Transdermal Drug Delivery System Sales and Growth, Sales Value and Growth Rate 2014-2020
    8.2 China Transdermal Drug Delivery System Sales and Growth, Sales Value and Growth Rate 2014-2020
    8.3 USA Transdermal Drug Delivery System Sales and Growth, Sales Value and Growth Rate2014-2020
    8.4 Europe Transdermal Drug Delivery System Sales and Growth, Sales Value and Growth Rate 2014-2020
    8.5 Japan Transdermal Drug Delivery System Sales and Growth, Sales Value and Growth Rate 2014-2020
    8.6 Korea Transdermal Drug Delivery System Sales and Growth, Sales Value and Growth Rate 2014-2020
    8.7 India Transdermal Drug Delivery System Sales and Growth, Sales Value and Growth Rate 2014-2020
    8.8 Southeast Asia Transdermal Drug Delivery System Sales and Growth, Sales Value and Growth Rate 2014-2020
    8.8 Southeast Asia Transdermal Drug Delivery System Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
    9.1 Upstream Source
    9.2 Technology
    9.3 Cost
10 Channel Analysis
    10.1 Market Channel
    10.2 Manufacturing Plants Distribution
11 Consumer Analysis
    11.1 OTC Industry
    11.2 Rx Industry
12 Market Forecast 2021-2026
    12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
        12.1.1 Global Transdermal Drug Delivery System Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
        12.1.2 Global Transdermal Drug Delivery System Sales (K Units) and Growth Rate 2021-2026
        12.1.3 China Transdermal Drug Delivery System Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
        12.1.4 USA Transdermal Drug Delivery System Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
        12.1.5 Europe Transdermal Drug Delivery System Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
        12.1.6 Japan Transdermal Drug Delivery System Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
        12.1.7 Korea Transdermal Drug Delivery System Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
        12.1.8 India Transdermal Drug Delivery System Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
        12.1.9 Southeast Asia Transdermal Drug Delivery System Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
        12.1.10 South America Transdermal Drug Delivery System Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
        12.2.1 Overall Market Performance
        12.2.2 Fentanyl
        12.2.3 Nitroglycerin
        12.2.4 Estradiol
        12.2.5 Nicotine
        12.2.6 Other
    12.3 Sales  (K Units) Forecast by Application 2021-2026
        12.3.1 Overall Market Performance
        12.3.2 OTC
        12.3.3 Rx
    12.4 Price (USD/Unit) and Gross Profit
        12.4.1 Global Transdermal Drug Delivery System Price (USD/Unit) Trend 2021-2026
        12.4.2 Global Transdermal Drug Delivery System Gross Profit Trend 2021-2026
13 Conclusion

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports 203, 2nd Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).

Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2020 Worldwide Market Reports. All rights reserved